Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.
Exela Technologies Shares Move To Session High Following Co. Press Release Highlighting Co. Has Been Recognized As A ‘Major Contender’ In Everest Group’s Finance & Accounting Outsourcing 2021 PEAK Matrix
Exela Technologies, Inc. (“Exela”) (NASDAQ:XELA), a leading provider of Business Process Automation solutions, today announced that it has been recognized as a ‘Major Contender’ in Everest
